阿特珠单抗联合贝伐珠单抗减量治疗肝癌化疗疗效与贝伐珠单抗相关不良反应鼻出血的病例

{"title":"阿特珠单抗联合贝伐珠单抗减量治疗肝癌化疗疗效与贝伐珠单抗相关不良反应鼻出血的病例","authors":"Keisuke Sakaguchi, Masayuki Miyazaki, Yuichi Tachibana, Akihiro Ueda, Tetsuro Akashi","doi":"10.2957/kanzo.65.31","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17925,"journal":{"name":"Kanzo","volume":"121 13","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A case of chemotherapy efficacy with atezolizumab plus bevacizumab dose reduction for hepatocellular carcinoma against nasal hemorrhage as bevacizumab-related adverse event\",\"authors\":\"Keisuke Sakaguchi, Masayuki Miyazaki, Yuichi Tachibana, Akihiro Ueda, Tetsuro Akashi\",\"doi\":\"10.2957/kanzo.65.31\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17925,\"journal\":{\"name\":\"Kanzo\",\"volume\":\"121 13\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kanzo\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2957/kanzo.65.31\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kanzo","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2957/kanzo.65.31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}